Combination use of ivabradine with sacubitril/valsartan a review of clinical effectiveness and guidelines
The objective of this report is to provide a summary of the evidence of clinical effectiveness and clinical practice guidelines regarding the combination of ivabradine and sacubitril/valsartan for the treatment of heart failure
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, February 13, 2020
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this report is to provide a summary of the evidence of clinical effectiveness and clinical practice guidelines regarding the combination of ivabradine and sacubitril/valsartan for the treatment of heart failure |
|---|---|
| Physical Description: | 1 PDF file (10 pages) illustrations |